The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Gene-engineered T cells for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Morgan, R. A., Yang, J. C., Kitano, M., Dudley, M. E., Laurencot, C. M., & Rosenberg, S. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.24 · Cited by 2,533
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
Kochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Johnson, L. A., Morgan, R. A., Dudley, M. E., Cassard, L., Yang, J. C., Hughes, M. S., Kammula, U. S., Royal, R. E., Sherry, R. M., Wunderlich, J. R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211714 · Cited by 1,418
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
Brentjens, R. J., Rivière, I., Park, J. H., Davila, M. L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348540 · Cited by 1,286
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Kershaw, M. H., Westwood, J. A., Parker, L. L., Wang, G., Eshhar, Z., Mavroukakis, S. A., White, D. E., Wunderlich, J. R., Canevari, S., Rogers-Freezer, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1183 · Cited by 1,254
Self-citationMilone, M. C., Fish, J. D., Carpenito, C., Carroll, R. G., Binder, G. K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.83 · Cited by 1,197
Pule, M. A., Savoldo, B., Myers, G. D., Rossig, C., Russell, H. V., Dotti, G., Huls, M. H., Liu, E., Gee, A. P., Mei, Z., et al. (2008) · Nature Medicine · doi:10.1038/nm.1882 · Cited by 1,195
Linette, G. P., Stadtmauer, E. A., Maus, M. V., Rapoport, A. P., Levine, B. L., Emery, L., Litzky, L., Bagg, A., Carreno, B. M., Cimino, P. J., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490565 · Cited by 1,179
Louis, C. U., Savoldo, B., Dotti, G., Pule, M., Yvon, E., Myers, G. D., Rossig, C., Russell, H. V., Diouf, O., Liu, E., et al. (2011) · Blood · doi:10.1182/blood-2011-05-354449 · Cited by 1,163
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., et al. (1997) · Science · doi:10.1126/science.276.5319.1719 · Cited by 1,161
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Savoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46110 · Cited by 1,023
Parkhurst, M. R., Yang, J. C., Langan, R. C., Dudley, M. E., Nathan, D.-A. N., Feldman, S. A., Davis, J. L., Morgan, R. A., Merino, M. J., Sherry, R. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.272 · Cited by 1,020
Lamers, C. H. J., Sleijfer, S., Vulto, A. G., Kruit, W. H. J., Kliffen, M., Debets, R., Gratama, J. W., Stoter, G., & Oosterwijk, E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9964 · Cited by 915
Carpenito, C., Milone, M. C., Hassan, R., Simonet, J. C., Lakhal, M., Suhoski, M. M., Varela-Rohena, A., Haines, K. M., Heitjan, D. F., Albelda, S. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813101106 · Cited by 888
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M., & Sadelain, M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2459 · Cited by 857
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
An inducible caspase 9 safety switch for T-cell therapy
Straathof, K. C., Pulè, M. A., Yotnda, P., Dotti, G., Vanin, E. F., Brenner, M. K., Heslop, H. E., Spencer, D. M., & Rooney, C. M. (2005) · Blood · doi:10.1182/blood-2004-11-4564 · Cited by 742
Till, B. G., Jensen, M. C., Wang, J., Chen, E. Y., Wood, B. L., Greisman, H. A., Qian, X., James, S. E., Raubitschek, A., Forman, S. J., et al. (2008) · Blood · doi:10.1182/blood-2007-12-128843 · Cited by 722
Lamers, C. H., Sleijfer, S., van Steenbergen, S., van Elzakker, P., van Krimpen, B., Groot, C., Vulto, A., den Bakker, M., Oosterwijk, E., Debets, R., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.17 · Cited by 704
Pegram, H. J., Lee, J. C., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 678
Brentjens, R. J., Latouche, J.-B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D., Larson, S., Weiss, M., Rivière, I., et al. (2003) · Nature Medicine · doi:10.1038/nm827 · Cited by 669
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
Park, J. R., DiGiusto, D. L., Slovak, M., Wright, C., Naranjo, A., Wagner, J., Meechoovet, H. B., Bautista, C., Chang, W.-C., Ostberg, J. R., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300104 · Cited by 603
Wang, X., Chang, W.-C., Wong, C. W., Colcher, D., Sherman, M., Ostberg, J. R., Forman, S. J., Riddell, S. R., & Jensen, M. C. (2011) · Blood · doi:10.1182/blood-2011-02-337360 · Cited by 600
Paths to stemness: building the ultimate antitumour T cell
Gattinoni, L., Klebanoff, C. A., & Restifo, N. P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3322 · Cited by 599
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Haso, W., Lee, D. W., Shah, N. N., Stetler-Stevenson, M., Yuan, C. M., Pastan, I. H., Dimitrov, D. S., Morgan, R. A., FitzGerald, D. J., Barrett, D. M., et al. (2013) · Blood · doi:10.1182/blood-2012-06-438002 · Cited by 572
Chmielewski, M., Kopecky, C., Hombach, A. A., & Abken, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0103 · Cited by 562
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Zhong, X.-S., Matsushita, M., Plotkin, J., Riviere, I., & Sadelain, M. (2010) · Molecular Therapy · doi:10.1038/mt.2009.210 · Cited by 543
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Di Stasi, A., De Angelis, B., Rooney, C. M., Zhang, L., Mahendravada, A., Foster, A. E., Heslop, H. E., Brenner, M. K., Dotti, G., & Savoldo, B. (2009) · Blood · doi:10.1182/blood-2009-03-209650 · Cited by 533
Restifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J. R., & Rosenberg, S. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.100 · Cited by 533
Till, B. G., Jensen, M. C., Wang, J., Qian, X., Gopal, A. K., Maloney, D. G., Lindgren, C. G., Lin, Y., Pagel, J. M., Budde, L. E., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387969 · Cited by 529
Jensen, M. C., Popplewell, L., Cooper, L. J., DiGiusto, D., Kalos, M., Ostberg, J. R., & Forman, S. J. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.03.014 · Cited by 529
Torikai, H., Reik, A., Liu, P.-Q., Zhou, Y., Zhang, L., Maiti, S., Huls, H., Miller, J. C., Kebriaei, P., Rabinovitch, B., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405365 · Cited by 528
Craddock, J. A., Lu, A., Bear, A., Pule, M., Brenner, M. K., Rooney, C. M., & Foster, A. E. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ee6675 · Cited by 513
Pulè, M. A., Straathof, K. C., Dotti, G., Heslop, H. E., Rooney, C. M., & Brenner, M. K. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.016 · Cited by 487
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
Motz, G. T., & Coukos, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3064 · Cited by 481
Wilkie, S., van Schalkwyk, M. C. I., Hobbs, S., Davies, D. M., van der Stegen, S. J. C., Pereira, A. C. P., Burbridge, S. E., Box, C., Eccles, S. A., & Maher, J. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9689-9 · Cited by 478
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Program, N. C. S., Wei, X., Walia, V., Lin, J. C., Teer, J. K., Prickett, T. D., Gartner, J., Davis, S., Stemke-Hale, K., Davies, M. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.810 · Cited by 471
Cohen, C. J., Zhao, Y., Zheng, Z., Rosenberg, S. A., & Morgan, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1450 · Cited by 469
Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts
Brentjens, R. J., Santos, E., Nikhamin, Y., Yeh, R., Matsushita, M., La Perle, K., Quintás-Cardama, A., Larson, S. M., & Sadelain, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0674 · Cited by 463
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Provasi, E., Genovese, P., Lombardo, A., Magnani, Z., Liu, P.-Q., Reik, A., Chu, V., Paschon, D. E., Zhang, L., Kuball, J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2700 · Cited by 448
Ritchie, D. S., Neeson, P. J., Khot, A., Peinert, S., Tai, T., Tainton, K., Chen, K., Shin, M., Wall, D. M., Hönemann, D., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.154 · Cited by 443
Self-citationClay, T. M., Custer, M. C., Sachs, J., Hwu, P., Rosenberg, S. A., & Nishimura, M. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.507 · Cited by 410
Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
Robbins, P. F., Li, Y. F., El-Gamil, M., Zhao, Y., Wargo, J. A., Zheng, Z., Xu, H., Morgan, R. A., Feldman, S. A., Johnson, L. A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6116 · Cited by 383
Lamers, C. H. J., Willemsen, R., van Elzakker, P., van Steenbergen-Langeveld, S., Broertjes, M., Oosterwijk-Wakka, J., Oosterwijk, E., Sleijfer, S., Debets, R., & Gratama, J. W. (2011) · Blood · doi:10.1182/blood-2010-07-294520 · Cited by 368
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Kuball, J., Dossett, M. L., Wolfl, M., Ho, W. Y., Voss, R.-H., Fowler, C., & Greenberg, P. D. (2007) · Blood · doi:10.1182/blood-2006-05-023069 · Cited by 365
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
Stanislawski, T., Voss, R.-H., Lotz, C., Sadovnikova, E., Willemsen, R. A., Kuball, J., Ruppert, T., Bolhuis, R. L. H., Melief, C. J., Huber, C., et al. (2001) · Nature Immunology · doi:10.1038/ni1001-962 · Cited by 362
Cohen, C. J., Li, Y. F., El-Gamil, M., Robbins, P. F., Rosenberg, S. A., & Morgan, R. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3986 · Cited by 361
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
Song, D.-G., Ye, Q., Poussin, M., Harms, G. M., Figini, M., & Powell, D. J. (2012) · Blood · doi:10.1182/blood-2011-03-344275 · Cited by 355
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Kerkar, S. P., Goldszmid, R. S., Muranski, P., Chinnasamy, D., Yu, Z., Reger, R. N., Leonardi, A. J., Morgan, R. A., Wang, E., Marincola, F. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58814 · Cited by 342
Berger, C., Flowers, M. E., Warren, E. H., & Riddell, S. R. (2006) · Blood · doi:10.1182/blood-2005-08-3503 · Cited by 334
Urbanska, K., Lanitis, E., Poussin, M., Lynn, R. C., Gavin, B. P., Kelderman, S., Yu, J., Scholler, N., & Powell, D. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3890 · Cited by 322
Guest, R. D., Hawkins, R. E., Kirillova, N., Cheadle, E. J., Arnold, J., O'Neill, A., Irlam, J., Chester, K. A., Kemshead, J. T., Shaw, D. M., et al. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000161397.96582.59 · Cited by 318
Bollard, C. M., Rössig, C., Calonge, M. J., Huls, M. H., Wagner, H.-J., Massague, J., Brenner, M. K., Heslop, H. E., & Rooney, C. M. (2002) · Blood · doi:10.1182/blood.v99.9.3179 · Cited by 316
Workshop R: Tumor Immunology, Abstract R1 bis R30
(2001) · Immunobiology · doi:10.1016/s0171-2985(04)70018-2 · Cited by 312
Morgan, R. A., Johnson, L. A., Davis, J. L., Zheng, Z., Woolard, K. D., Reap, E. A., Feldman, S. A., Chinnasamy, N., Kuan, C.-T., Song, H., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.041 · Cited by 311
Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8 + T Cells
Vizcardo, R., Masuda, K., Yamada, D., Ikawa, T., Shimizu, K., Fujii, S.-I., Koseki, H., & Kawamoto, H. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.006 · Cited by 309
Stephan, M. T., Ponomarev, V., Brentjens, R. J., Chang, A. H., Dobrenkov, K. V., Heller, G., & Sadelain, M. (2007) · Nature Medicine · doi:10.1038/nm1676 · Cited by 299
Kershaw, M. H., Wang, G., Westwood, J. A., Pachynski, R. K., Tiffany, H. L., Marincola, F. M., Wang, E., Young, H. A., Murphy, P. M., & Hwu, P. (2002) · Human Gene Therapy · doi:10.1089/10430340260355374 · Cited by 297
Self-citationZhao, Y., Wang, Q. J., Yang, S., Kochenderfer, J. N., Zheng, Z., Zhong, X., Sadelain, M., Eshhar, Z., Rosenberg, S. A., & Morgan, R. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900447 · Cited by 293
Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice
Klebanoff, C. A., Gattinoni, L., Palmer, D. C., Muranski, P., Ji, Y., Hinrichs, C. S., Borman, Z. A., Kerkar, S. P., Scott, C. D., Finkelstein, S. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0503 · Cited by 288
Song, D.-G., Ye, Q., Carpenito, C., Poussin, M., Wang, L.-P., Ji, C., Figini, M., June, C. H., Coukos, G., & Powell, D. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0422 · Cited by 287
Chinnasamy, D., Yu, Z., Kerkar, S. P., Zhang, L., Morgan, R. A., Restifo, N. P., & Rosenberg, S. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3050 · Cited by 277
In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
Hwu, P., Yang, J. C.-H., Cowherd, R., Treisman, J. S., Shafer, G., Eshhar, Z., & Rosenberg, S. A. (1995) · PubMed · Cited by 273
Hudecek, M., Schmitt, T. M., Baskar, S., Lupo-Stanghellini, M. T., Nishida, T., Yamamoto, T. N., Bleakley, M., Turtle, C. J., Chang, W.-C., Greisman, H. A., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283309 · Cited by 266
Chmielewski, M., Hombach, A., Heuser, C., Adams, G. P., & Abken, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7647 · Cited by 260
Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
Tamada, K., Geng, D., Sakoda, Y., Bansal, N., Srivastava, R., Li, Z., & Davila, E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1449 · Cited by 259
Kerkar, S. P., Muranski, P., Kaiser, A., Boni, A., Sanchez-Perez, L., Yu, Z., Palmer, D. C., Reger, R. N., Borman, Z. A., Zhang, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0735 · Cited by 254
Morgan, R. A., Dudley, M. E., Yu, Y. Y. L., Zheng, Z., Robbins, P. F., Theoret, M. R., Wunderlich, J. R., Hughes, M. S., Restifo, N. P., & Rosenberg, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3287 · Cited by 228
Brown, C. E., Starr, R., Aguilar, B., Shami, A. F., Martinez, C., D'Apuzzo, M., Barish, M. E., Forman, S. J., & Jensen, M. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1669 · Cited by 225
Zhao, Y., Bennett, A. D., Zheng, Z., Wang, Q. J., Robbins, P. F., Yu, L. Y. L., Li, Y., Molloy, P. E., Dunn, S. M., Jakobsen, B. K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5845 · Cited by 220
Gehring, A. J., Xue, S.-A., Ho, Z. Z., Teoh, D., Ruedl, C., Chia, A., Koh, S., Lim, S. G., Maini, M. K., Stauss, H., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.025 · Cited by 217
Ahmed, N., Salsman, V. S., Yvon, E., Louis, C. U., Perlaky, L., Wels, W. S., Dishop, M. K., Kleinerman, E. E., Pule, M., Rooney, C. M., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.133 · Cited by 215
Wang, J., Jensen, M., Lin, Y., Sui, X., Chen, E., Lindgren, C. G., Till, B., Raubitschek, A., Forman, S. J., Qian, X., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.028 · Cited by 213
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease
Thomis, D. C. (2001) · Blood · doi:10.1182/blood.v97.5.1249 · Cited by 205
Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors
Alkins, R., Burgess, A., Ganguly, M., Francia, G., Kerbel, R., Wels, W. S., & Hynynen, K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2609 · Cited by 197
Loskog, A., Giandomenico, V, Rossig, C., Pule, M., Dotti, G., & Brenner, M. K. (2006) · Leukemia · doi:10.1038/sj.leu.2404366 · Cited by 192
Okamoto, S., Mineno, J., Ikeda, H., Fujiwara, H., Yasukawa, M., Shiku, H., & Kato, I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1450 · Cited by 186
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene–transduced human T cells
Xue, S.-A., Gao, L., Hart, D., Gillmore, R., Qasim, W., Thrasher, A., Apperley, J., Engels, B., Uckert, W., Morris, E., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0146 · Cited by 186
Prosser, M. E., Brown, C. E., Shami, A. F., Forman, S. J., & Jensen, M. C. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.023 · Cited by 184
Heemskerk, M. H. M., Hoogeboom, M., Hagedoorn, R., Kester, M. G. D., Willemze, R., & Falkenburg, J. H. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031110 · Cited by 183
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
Ramos, C. A., & Dotti, G. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.573476 · Cited by 182
Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
Willemsen, R. A., Weijtens, M. E. M., Ronteltap, C., Eshhar, Z., Gratama, J. W., Chames, P., & Bolhuis, R. L. H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301253 · Cited by 170
T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies
Shaffer, D. R., Savoldo, B., Yi, Z., Chow, K. K. H., Kakarla, S., Spencer, D. M., Dotti, G., Wu, M.-F., Liu, H., Kenney, S., et al. (2011) · Blood · doi:10.1182/blood-2010-04-278218 · Cited by 167
Chinnasamy, N., Wargo, J. A., Yu, Z., Rao, M., Frankel, T. L., Riley, J. P., Hong, J. J., Parkhurst, M. R., Feldman, S. A., Schrump, D. S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001775 · Cited by 161
Chmielewski, M. M., Hahn, O., Rappl, G., Nowak, M. A., Schmidt‐Wolf, I. G. H., Hombach, A. A., & Abken, H. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.037 · Cited by 154
Westwood, J. A., Smyth, M. J., Teng, M. W. L., Moeller, M., Trapani, J. A., Scott, A. M., Smyth, F. E., Cartwright, G. A., Power, B. E., Hönemann, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504312102 · Cited by 148
Self-citationEradication of melanomas by targeted elimination of a minor subset of tumor cells
Schmidt, P., Kopecky, C., Hombach, A. A., Zigrino, P., Mauch, C., & Abken, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009069108 · Cited by 143
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Yvon, E. S., Vecchio, M. D., Savoldo, B., Hoyos, V., Dutour, A., Anichini, A., Dotti, G., & Brenner, M. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3163 · Cited by 141
Bcl-2 Overexpression Enhances Tumor-Specific T-Cell Survival
Charo, J., Finkelstein, S. E., Grewal, N. S., Restifo, N. P., Robbins, P. F., & Rosenberg, S. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2006 · Cited by 135
Palmer, D. C., Chan, C., Gattinoni, L., Wrzesinski, C., Paulos, C. M., Hinrichs, C. S., Powell, D. J., Klebanoff, C. A., Finkelstein, S. E., Fariss, R. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710929105 · Cited by 132
Davis, J. L., Theoret, M. R., Zheng, Z., Lamers, C. H. J., Rosenberg, S. A., & Morgan, R. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1280 · Cited by 132
Rational development of high-affinity T-cell receptor-like antibodies
Stewart-Jones, G., Wadle, A., Hombach, A., Shenderov, E., Held, G., Fischer, E., Kleber, S., Nuber, N., Stenner, F., Bauer, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901425106 · Cited by 128
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
Dotti, G., Savoldo, B., Pulè, M. A., Straathof, K. C. M., Biagi, E., Yvon, E. S., Vigouroux, S., Brenner, M. K., & Rooney, C. M. (2005) · Blood · doi:10.1182/blood-2004-08-3337 · Cited by 128
Huang, G., Yu, L., Cooper, L. J. N., Hollomon, M., Huls, H., & Kleinerman, E. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2778 · Cited by 127
CD3 limits the efficacy of TCR gene therapy in vivo
Ahmadi, M., King, J. P., Xue, S., Voisine, C., Holler, A., Wright, G. P., Waxman, J., Morris, E. C., & Stauss, H. J. (2011) · Blood · doi:10.1182/blood-2011-04-346338 · Cited by 121
Weide, B., Zelba, H., Derhovanessian, E., Pflugfelder, A., Eigentler, T., Giacomo, A. M. D., Maio, M., Aarntzen, E. H. J. G., de Vries, I. J. M., Sucker, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.2271 · Cited by 118
Jin, Z., Maiti, S. N., Huls, H. M., Singh, H., Olivares, S., Mátés, L., Izsvák, Z., Ivics, Z., Lee, D. A., Champlin, R. E., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.40 · Cited by 117
Rainusso, N., Brawley, V. S., Ghazi, A., Hicks, M. J., Gottschalk, S., Rosen, J. M., & Ahmed, N. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2011.83 · Cited by 114
Dual-specific T cells combine proliferation and antitumor activity
Kershaw, M. H., Westwood, J. A., & Hwu, P. (2002) · Nature Biotechnology · doi:10.1038/nbt756 · Cited by 114
Self-citationSpear, P., Barber, A., Rynda‐Apple, A., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103019 · Cited by 114
Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
Lipowska‐Bhalla, G., Gilham, D. E., Hawkins, R. E., & Rothwell, D. G. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1254-0 · Cited by 110
Vatakis, D. N., Koya, R. C., Nixon, C. C., Liu, W., Kim, S. G., Avancena, P., Bristol, G. C., Baltimore, D., Kohn, D. B., Ribas, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115050108 · Cited by 110
Cooper, L. J. N., Al-Kadhimi, Z. S., Serrano, L. M., Pfeiffer, T., Olivares, S., Castro, A., Chang, W.-C., Gonzalez, S., Smith, D. D., Forman, S. J., et al. (2004) · Blood · doi:10.1182/blood-2004-03-1208 · Cited by 109
Lee, J., Hayman, E. G., Pegram, H. J., Santos, E. B., Heller, G., Sadelain, M., & Brentjens, R. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0552 · Cited by 102
How do CARs work? Early insights from recent clinical studies targeting CD19
Davila, M. L., Brentjens, R. J., Wang, X., Rivière, I., & Sadelain, M. (2012) · OncoImmunology · doi:10.4161/onci.22524 · Cited by 102
Petrausch, U., Schuberth, P., Hagedorn, C., Soltermann, A., Tomaszek, S. C., Stahel, R. A., Weder, W., & Renner, C. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-615 · Cited by 100
Maliar, A., Servais, C., Waks, T., Chmielewski, M. M., Lavy, R., Altevogt, P., Abken, H., & Eshhar, Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.017 · Cited by 98
Scott, A. M., Geleick, D., Rubira, M. R., Clarke, K., Nice, E. C., Smyth, F. E., Stockert, E., Richards, E. C., Carr, F. J., Harris, W. J., et al. (2000) · PubMed · Cited by 97
Koehler, H., Kofler, D. M., Hombach, A. A., & Abken, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2098 · Cited by 95
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer
Kieback, E., Charo, J., Sommermeyer, D., Blankenstein, T. J. F., & Uckert, W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710198105 · Cited by 94
Burns, W. R., Zhao, Y., Frankel, T. L., Hinrichs, C. S., Zheng, Z., Xu, H., Feldman, S. A., Ferrone, S., Rosenberg, S. A., & Morgan, R. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2824 · Cited by 89
Stromnes, I. M., Blattman, J. N., Tan, X., Jeevanjee, S., Gu, H., & Greenberg, P. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41991 · Cited by 87
Leisegang, M., Wilde, S., Spranger, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43437 · Cited by 87
Shin, J. H., Park, H. B., Oh, Y. M., Lim, D. P., Lee, J. E., Seo, H. H., Lee, S. J., Eom, H., Kim, I.-H., Lee, S. H., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380519 · Cited by 86
Emtage, P. C. R., Lo, A. S., Gomes, E. M., Liu, D. L., Gonzalo‐Daganzo, R. M., & Junghans, R. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4910 · Cited by 81
Cheadle, E. J., Hawkins, R. E., Batha, H., O’Neill, A. L., Dovedi, S. J., & Gilham, D. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901440 · Cited by 79
Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma
Barber, A., Zhang, T., Megli, C., Wu, J., Meehan, K. R., & Sentman, C. L. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.04.010 · Cited by 78
Turatti, F., Figini, M., Balladore, E., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3180de5d90 · Cited by 77
Altenschmidt, U., Kahl, R., Moritz, D. R., Schnierle, B. S., Gerstmayer, B., Wels, W. S., & Groner, B. (1996) · PubMed · Cited by 77
Westwood, J. A., Murray, W. K., Trivett, M. K., Haynes, N. M., Solomon, B., Mileshkin, L., Ball, D., Michael, M., Burman, A. C., Mayura-Guru, P., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819b7c8e · Cited by 74
Self-citationDuval, L., Schmidt, H., Kaltoft, K., Fode, K., Jensen, J. J., Soerensen, S. M., Nishimura, M. I., & von der Maase, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1485 · Cited by 73
Burns, W. R., Zheng, Z., Rosenberg, S. A., & Morgan, R. A. (2009) · Blood · doi:10.1182/blood-2009-01-199216 · Cited by 70
T Cells Expressing Constitutively Active Akt Resist Multiple Tumor-associated Inhibitory Mechanisms
Sun, J., Dotti, G., Huye, L. E., Foster, A. E., Savoldo, B., Gramatges, M. M., Spencer, D. M., & Rooney, C. M. (2010) · Molecular Therapy · doi:10.1038/mt.2010.185 · Cited by 69
Rosenberg, S. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.195 · Cited by 69
Stromnes, I. M., Fowler, C., Casamina, C. C., Georgopolos, C. M., McAfee, M. S., Schmitt, T. M., Tan, X., Kim, T., Choi, I., Blattman, J. N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200552 · Cited by 68
Willemsen, R. A., Ronteltap, C. P. M., Chames, P., Debets, R., & Bolhuis, R. L. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7853 · Cited by 67
Ertl, H. C. J., Zaia, J. A., Rosenberg, S. A., June, C. H., Dotti, G., Kahn, J. P., Cooper, L. J. N., Corrigan‐Curay, J., & Strome, S. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4035 · Cited by 67
Koya, R. C., Mok, S., Comín-Anduix, B., Chodon, T., Radu, C. G., Nishimura, M. I., Witte, O. N., & Ribas, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008300107 · Cited by 65
Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach
Duong, C. P. M., Westwood, J. A., Yong, C. S. M., Murphy, A., Devaud, C., John, L. B., Darcy, P. K., & Kershaw, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063037 · Cited by 64
Self-citationSingle-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains
Aggen, D. H., Chervin, A. S., Schmitt, T. M., Engels, B., Stone, J. D., Richman, S. A., Piepenbrink, K. H., Baker, B. M., Greenberg, P. D., Schreiber, H. W., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.104 · Cited by 64
Moeller, M., Haynes, N. M., Trapani, J. A., Teng, M. W. L., Jackson, J. T., Tanner, J. E., Cerruti, L., Jane, S. M., Kershaw, M. H., Smyth, M. J., et al. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700710 · Cited by 62
Self-citationEaton, D., Gilham, D. E., O'Neill, A., & Hawkins, R. E. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301685 · Cited by 61
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo
Spranger, S., Jeremias, I., Wilde, S., Leisegang, M., Stärck, L., Mosetter, B., Uckert, W., Heemskerk, M. H. M., Schendel, D. J., & Frankenberger, B. (2012) · Blood · doi:10.1182/blood-2011-06-357939 · Cited by 60
Borkner, L., Kaiser, A., van de Kasteele, W., Andreesen, R., Mackensen, A., Haanen, J. B. A. G., Schumacher, T. N., & Blank, C. U. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0842-0 · Cited by 57
A Coreceptor-Independent Transgenic Human TCR Mediates Anti-Tumor and Anti-Self Immunity in Mice
Mehrotra, S., Al-Khami, A. A., Klarquist, J. S., Husain, S., Naga, O. S., Eby, J. M., Murali, A. K., Lyons, G. E., Li, M., Spivey, N. D., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103271 · Cited by 56
Mihara, K., Yanagihara, K., Takigahira, M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08297.x · Cited by 52
Riët, T., Holzinger, A., Dörrie, J., Schaft, N., Schuler, G., & Abken, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_12 · Cited by 49
Enhancing the Specificity of T-Cell Cultures for Adoptive Immunotherapy of Cancer
Duong, C. P. M., Westwood, J. A., Berry, L. J., Darcy, P. K., & Kershaw, M. H. (2010) · Immunotherapy · doi:10.2217/imt.10.81 · Cited by 49
Self-citationGenetically engineered T cells as adoptive immunotherapy of cancer.
Ma, Q., Gonzalo‐Daganzo, R. M., & Junghans, R. P. (2002) · PubMed · Cited by 48
Cheadle, E. J., Rothwell, D. G., Bridgeman, J. S., Sheard, V., Hawkins, R. E., & Gilham, D. E. (2011) · Gene Therapy · doi:10.1038/gt.2011.192 · Cited by 48
Challenges in T cell receptor gene therapy
Uttenthal, B. J., Chua, I. C., Morris, E. C., & Stauss, H. J. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2637 · Cited by 45
Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation
Lo, A. S., Taylor, J. R., Farzaneh, F., Kemeny, D. M., Dibb, N. J., & Maher, J. F. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.09.010 · Cited by 45
TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation
de Witte, M. A., Bendle, G. M., van den Boom, M. D., Coccoris, M., Schell, T. D., Tevethia, S. S., van Tinteren, H., Mesman, E., Song, J., & Schumacher, T. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2563 · Cited by 42
Dossett, M. L., Teague, R. M., Schmitt, T. M., Tan, X., Cooper, L. J. N., Pinzon, C., & Greenberg, P. D. (2009) · Molecular Therapy · doi:10.1038/mt.2008.300 · Cited by 42
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies
van Loenen, M. M., de Boer, R., Hagedoorn, R. S., van Egmond, E. H. M., Falkenburg, J. H. F., & Heemskerk, M. H. M. (2010) · Haematologica · doi:10.3324/haematol.2010.025916 · Cited by 41
About human tumor antigens to be used in immunotherapy
Lucas, S., & Coulie, P. G. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.02.001 · Cited by 41
Kershaw, M. H., Westwood, J. A., Zhu, Z., Witte, L., Libutti, S. K., & Hwu, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050207939 · Cited by 40
Self-citationLeisegang, M., Turqueti‐Neves, A., Engels, B., Blankenstein, T. J. F., Schendel, D. J., Uckert, W., & Noeßner, E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2897 · Cited by 36
Hillerdal, V., Nilsson, B., Carlsson, B., Eriksson, F., & Essand, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209042109 · Cited by 33
Scholten, K. B. J., Turksma, A. W., Ruizendaal, J. J., van den Hende, M., van der Burg, S. H., Heemskerk, M. H. M., Meijer, C. J. L. M., & Hooijberg, E. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-147 · Cited by 33
Redirected tumor-specific allogeneic T cells for universal treatment of cancer
Marcus, A., Waks, T., & Eshhar, Z. (2011) · Blood · doi:10.1182/blood-2011-02-334284 · Cited by 32
Nagai, K., Ochi, T., Fujiwara, H., An, J., Shirakata, T., Mineno, J., Kuzushima, K., Shiku, H., Melenhorst, J. J., Emma Gostick, D., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360354 · Cited by 28
Shirakura, Y., Mizuno, Y., Wang, L., Imai, N., Amaike, C., Sato, E., Ito, M., Nukaya, I., Mineno, J., Takesako, K., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02111.x · Cited by 27
Cheung, N. V., Guo, H.-F., Modak, S. I., & Cheung, I. Y. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903322328938 · Cited by 26
Adjusting transgene expression levels in lymphocytes with a set of inducible promoters
Danke, C., Grünz, X., Wittmann, J., Schmidt, A., Agha‐Mohammadi, S., Kutsch, O., Jäck, H., Hillen, W., & Berens, C. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1461 · Cited by 25
Kunii, N., Zhao, Y., Jiang, S., Liu, X., Scholler, J., Balagopalan, L., Samelson, L. E., Milone, M. C., & June, C. H. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.130 · Cited by 22
Knockdown of human bid gene expression enhances survival of CD8+ T cells
Lei, X.-Y., Xu, Y., Wang, T., Xie, Q., Jia, L., Wang, L., Jin, B., Yan, Z., Yao, L.-B., & Yang, A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.10.009 · Cited by 12
Rapoport, A. P., Stadtmauer, E. A., Vogl, D. T., Weiss, B. M., Binder-Scholl, G. K., Brewer, J. E., Bennett, A., Gerry, A. B., Pumphrey, N. J., Smethurst, D. P., et al. (2012) · Blood · doi:10.1182/blood.v120.21.472.472 · Cited by 12
Cytotoxic T Lymphocyte Trafficking and Survival in an Augmented Fibrin Matrix Carrier
Zou, Z., Denny, E. C., Brown, C. E., Jensen, M. C., Li, G., Fujii, T., Neman, J., Jandial, R., & Chen, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034652 · Cited by 7
Cited by
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Farhood, B., Najafi, M., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27782 · Cited by 1,658
Kochenderfer, J. N., Dudley, M. E., Kassim, S. H., Somerville, R. P. T., Carpenter, R. O., Stetler-Stevenson, M., Yang, J. C., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2025 · Cited by 1,595
Classifying Cancers Based on T-cell Infiltration and PD-L1
Teng, M. W. L., Ngiow, S. F., Ribas, A., & Smyth, M. J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0255 · Cited by 1,411
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Melero, I., Berman, D. M., Aznar, M. A., Korman, A. J., Gracia, J. L. P., & Haanen, J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3973 · Cited by 637
Metadata
- Authors
- Kershaw, M. H., Westwood, J. A., & Darcy, P. K.
- Venue
- Nature Reviews Cancer
- Published
- 2013-07-24
- Volume
- 13
- Issue
- 8
- Pages
- 525-541
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2093762704
- Cited by
- 505
- References
- 176
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.